started · updated
Cancer treatment trends and survival challenges in Japan
In Japan, approximately one million people are diagnosed with cancer annually, with roughly half of the population expected to face a diagnosis in their lifetime. While over 60 percent of cases are now curable, certain types of cancer continue to present significant survival challenges due to difficulties in early detection and high recurrence rates.
Specific cancers with lower five-year survival rates include pancreatic cancer, biliary tract cancer, small cell lung cancer, and liver cancer. Pancreatic and biliary cancers are often difficult to detect in early stages because they frequently lack clear symptoms until the disease has progressed. Small cell lung cancer is characterized by rapid growth and early metastasis, while liver cancer is often linked to underlying chronic conditions like hepatitis, which can complicate treatment and increase recurrence risks.
Modern medical approaches emphasize multidisciplinary treatment, which combines surgery, radiation, and drug therapies to maximize effectiveness and minimize recurrence. This approach is supported by team-based care involving surgeons, oncologists, nurses, and nutritionists to manage side effects and maintain a patient's quality of life. Additionally, patients are encouraged to utilize second opinions to ensure they are fully informed and confident in their chosen treatment paths.